["{\n\"step_by_step_thinking\": \"The patient is a 71-year-old woman with impaired memory and poor orientation in space. She tends to forget newly introduced information and got lost on the way from home to the local market several times for the past 6 months. The neurological examination shows no significant abnormalities, but the Montreal Cognitive Assessment score of 18 suggests mild cognitive impairment. Given her symptoms and family history (father had dementia), a possible diagnosis of early-stage Alzheimer's disease is considered. Since there are no other concomitant conditions or major cardiovascular events/head trauma, medication is not indicated for those reasons. The focus is on managing the patient's cognitive symptoms. Donepezil is an FDA-approved medication for treating mild cognitive impairment and early-stage Alzheimer's disease, which is consistent with this patient's diagnosis.\",\n\"answer_choice\": C"]